| Literature DB >> 26225984 |
Bin Wu1,2, Jutta Wiese3, Antje Labes4, Annemarie Kramer5, Rolf Schmaljohann6, Johannes F Imhoff7.
Abstract
An unusual polyketide with a new carbon skeleton, lindgomycin (1), and the recently described ascosetin (2) were extracted from mycelia and culture broth of different Lindgomycetaceae strains, which were isolated from a sponge of the Kiel Fjord in the Baltic Sea (Germany) and from the Antarctic. Their structures were established by spectroscopic means. In the new polyketide, two distinct domains, a bicyclic hydrocarbon and a tetramic acid, are connected by a bridging carbonyl. The tetramic acid substructure of compound 1 was proved to possess a unique 5-benzylpyrrolidine-2,4-dione unit. The combination of 5-benzylpyrrolidine-2,4-dione of compound 1 in its tetramic acid half and 3-methylbut-3-enoic acid pendant in its decalin half allow the assignment of a new carbon skeleton. The new compound 1 and ascosetin showed antibiotic activities with IC50 value of 5.1 (±0.2) µM and 3.2 (±0.4) μM, respectively, against methicillin-resistant Staphylococcus aureus.Entities:
Keywords: MRSA; antibiotic; lindgomycin; marine fungi; marine natural products
Mesh:
Substances:
Year: 2015 PMID: 26225984 PMCID: PMC4556996 DOI: 10.3390/md13084617
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1Lindgomycetaceae strain KF970, agar colony on WSP30 medium after 21 days of incubation at 22 °C.
Figure 2Structures of compounds 1 and 2.
NMR data (500 MHz) for compounds 1 and 2 in CD3OD.
| Position | 1 | 2 | ||
|---|---|---|---|---|
| δC a,b, Mult. | δH
c, Mult. ( | δC a,b, Mult. | δH
c, Mult. ( | |
| 1 | 201.4, C | 202.3, C | ||
| 2 | 52.2, C | 52.7, C | ||
| 3α | 58.0, CH | 3.46, s | 57.9, CH | 3.52, s |
| 4 | 130.8, C | 130.9, C | ||
| 5 | 129.5, CH | 5.41, br s | 129.6, CH | 5.43, br s |
| 6α | 39.9, CH | 1.88, m | 39.8, CH | 1.90, m |
| 7α | 43.7, CH2 | 1.87, m | 43.8, CH2 | 1.88, m |
| 7β | 0.90, m | 0.86, m | ||
| 8α | 34.8, CH | 1.54, m | 34.8, CH | 1.56, m |
| 9α | 37.1, CH2 | 1.73, m | 37.1, CH2 | 1.67, m |
| 9β | 1.05, m | 1.06, m | ||
| 10α | 29.6, CH2 | 0.95, m | 29.6, CH2 | 1.07, m |
| 10β | 1.71, m | 1.76, m | ||
| 11β | 41.6, CH | 1.81, m | 41.8, CH | 1.87, m |
| 12 | 15.6, CH3 | 1.38, s | 15.6, CH3 | 1.49, s |
| 13 | 159.8, C | 159.9, C | ||
| 14 | 121.5, CH | 5.63, s | 121.6, CH | 5.66, s |
| 15 | 169.6, C | 169.6, C | ||
| 16 | 17.3, CH3 | 1.91, s | 17.2, CH3 | 1.97, s |
| 17 | 22.9, CH3 | 0.93, d ( | 22.9, CH3 | 0.92, d ( |
| 18 | 22.9, CH3 | 1.54, s | 22.8, CH3 | 1.55, s |
| 2′ | 173.0, C | 173.0, C | ||
| 3′ | n.d. | n.d. | ||
| 4′ | 194.1, C | 195.8, C | ||
| 5′ | 62.2, CH | 4.07, dd ( | 60.4, CH | 3.90, m |
| 6′a | 38.5, CH2 | 3.09 dd ( | 42.4, CH2 | 1.85, m |
| 6′b | 2.96 dd ( | 0.90, m | ||
| 7′ | 136.9, C | 22.1, CH | 1.50, m | |
| 8′ | 130.8, CH | 7.19, d ( | 23.9, CH3 | 0.97, d ( |
| 9′ | 129.3, CH | 7.24, t ( | 22.89, CH3 | 0,95, d ( |
| 10′ | 127.9, CH | 7.21, t ( | ||
| 11′ | 129.3, CH | 7.24, t ( | ||
| 12′ | 130.8, CH | 7.19, d ( | ||
a Recorded at 125 MHz; b Multiplicities inferred from DEPT and HMQC experiments; c Recorded at 500 MHz.
Figure 3Key 1H–1H COSY and HMBC correlations of compound 1.
Figure 4Key NOESY correlations of compound 1.
Antibiotic profiles of compounds 1 and 2. The IC50 values are given in µM.
| Test Strain | 1 | 2 | Positive Controls |
|---|---|---|---|
|
| 2.2 (±0.6) | 3.4 (±1.1) | chloramphenicol: 1.45 (±0.13) |
|
| 17.8 (±1.6) | 14.8 (±0.7) | chloramphenicol: 2.88 (±0.9) |
|
| 4.6 (±0.8) | 6.3 (±0.7) | chloramphenicol: 1.81 (±0.04) |
|
| 2.7 (±0.56) | 2.9 (±1.1) | chloramphenicol: 1.59 (±0.07) |
| 5.1 (±0.2) | 3.2 (±0.4) | chloramphenicol: 2.46 (±0.04) | |
|
| 5.7 (±0.9) | 8.0 (±1.4) | nystatin: 1.71 (±0.28) |
|
| 5.1 (±0.7) | 10.0 (±3.1) | nystatin: 0.76 (±0.23) |
|
| 4.7 (±0.4) | 2.8 (±0.7) | chloramphenicol: 1.01 (±0.01) |
|
| >100 | >100 | chloramphenicol: 373 (±0.10) |
|
| >200 | >200 | chloramphenicol: 8.86 (±0.36) |